A Clinical Study Evaluating the Diagnostic Performance and Safety of PET for the Deposition of Aβ Plaques in the Brain of Participants With Normal Cognitive Function, MCI and AD Using [18F]Fluorbetazine Injection

Clinical trial NCT07764679 · RECRUITING

Trial details

NCT number: NCT07764679
Sponsor: HTA Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Mild Cognitive Impairment (MCI)Alzheimer's Disease (AD)

Start date: 2025-06-20
Primary completion: 2027-12-31
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.